BRGAY logo

Borregaard ASA Unsponsored ADR (BRGAY) Análisis de Acciones

Solo con fines informativos. No es asesoramiento financiero. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

Cotizando a $, Borregaard ASA Unsponsored ADR (BRGAY) es una empresa del sector Basic Materials valorada en 0. Calificado con 49/100 (cauteloso) en potencial de crecimiento, salud financiera e impulso.

Ultimo analisis: 17 mar 2026
Puntuación de IA de 49/100

Borregaard ASA Unsponsored ADR (BRGAY) Exposición a Materiales y Productos Básicos

CEOTom Erik Foss-Jacobsen
Empleados1174
Sede CentralSarpsborg, NO
Año de la oferta pública inicial (OPI)2016
IndustriaChemicals

Borregaard ASA is a global leader in sustainable biomaterials, biochemicals, and biofuels, differentiating itself through its integrated biorefinery concept and focus on high-value applications across diverse industries. The company leverages its proprietary technology and sustainable sourcing to maintain a competitive edge in the chemicals sector.

Procedencia de los datos | Datos financieros Análisis cuantitativo NASDAQ Análisis: 17 mar 2026

Tesis de Inversión

Borregaard ASA presents a compelling investment thesis based on its leading position in the sustainable biomaterials market and its integrated biorefinery model. With a P/E ratio of 27.37 and a profit margin of 8.0%, the company demonstrates solid profitability. Growth catalysts include increasing demand for sustainable alternatives to fossil-based products and expansion into new applications for its biomaterials. The company's dividend yield of 2.50% provides an additional incentive for investors. Key risks include fluctuations in raw material prices and regulatory changes impacting the chemicals industry. The company's beta of 0.74 suggests lower volatility compared to the broader market.

Basado en las finanzas de FMP y el análisis cuantitativo

Puntos clave

  • Market capitalization of $0.88 billion reflects Borregaard's established position in the biomaterials market.
  • Profit margin of 8.0% indicates efficient operations and strong pricing power.
  • Gross margin of 20.4% demonstrates the value-added nature of Borregaard's specialized products.
  • Dividend yield of 2.50% provides a steady income stream for investors.
  • Beta of 0.74 suggests lower volatility compared to the broader market, making it a potentially stable investment.

Competidores y Pares

Fortalezas

  • Integrated biorefinery model for efficient production.
  • Proprietary technology and know-how.
  • Sustainable sourcing and environmentally friendly practices.
  • Diverse product portfolio.

Debilidades

  • Exposure to fluctuations in raw material prices (wood).
  • Dependence on specific industries for product demand.
  • Limited brand recognition compared to larger chemical companies.
  • Geographic concentration in Europe.

Catalizadores

  • Ongoing: Increasing demand for sustainable biomaterials driven by environmental regulations and consumer preferences.
  • Ongoing: Expansion of biovanillin applications in the food and beverage industry.
  • Upcoming: Potential partnerships with companies in the agrochemical and battery sectors to utilize biopolymers.
  • Upcoming: Development of new biofuel technologies to capitalize on the growing demand for renewable energy sources.

Riesgos

  • Potential: Fluctuations in raw material prices (wood) impacting profitability.
  • Potential: Regulatory changes affecting the chemicals industry and biomaterial production.
  • Ongoing: Currency risk associated with the Norwegian Krone (NOK).
  • Ongoing: Limited liquidity and price volatility due to trading on the OTC market.
  • Potential: Increased competition from other biomaterial producers.

Oportunidades de crecimiento

  • Expansion of BioSolutions Segment: The BioSolutions segment has a significant growth opportunity in expanding the applications of its biopolymers. The market for biopolymers in agrochemicals, batteries, industrial binders, and construction is projected to grow substantially as industries seek sustainable alternatives. Borregaard can leverage its existing technology and customer relationships to capture a larger share of this market, potentially increasing revenue by 15-20% over the next five years.
  • Increased Demand for Biovanillin: The demand for biovanillin in the flavor and fragrance industries, as well as the food and beverage sector, is expected to rise due to consumer preferences for natural and sustainable ingredients. Borregaard's biovanillin offers a sustainable alternative to synthetic vanillin, positioning the company to benefit from this trend. By increasing production capacity and expanding its distribution network, Borregaard could see a 10-15% increase in biovanillin sales within the next three years.
  • Growth in Specialty Cellulose Applications: The BioMaterials segment can capitalize on the growing demand for specialty cellulose in the production of cellulose ethers, cellulose acetate, and other specialty products. These materials are used in a wide range of applications, including textiles, pharmaceuticals, and construction. Borregaard can focus on developing new and innovative applications for its specialty cellulose to drive growth in this segment, potentially increasing revenue by 12-18% over the next five years.
  • Penetration of New Geographic Markets: Borregaard has the opportunity to expand its geographic reach by penetrating new markets in Asia and other regions. These markets are experiencing rapid economic growth and increasing demand for sustainable products. By establishing strategic partnerships and investing in local sales and marketing efforts, Borregaard can tap into these new markets and drive revenue growth. This expansion could contribute to a 8-12% increase in overall revenue within the next four years.
  • Development of New Biofuel Technologies: The Fine Chemicals segment can explore the development of new biofuel technologies to capitalize on the growing demand for renewable energy sources. Bioethanol, a key product of this segment, can be further developed and optimized to improve its efficiency and reduce its environmental impact. By investing in research and development, Borregaard can position itself as a leader in the biofuel market and drive long-term growth. This could lead to a 5-10% increase in revenue within the next five to seven years.

Oportunidades

  • Expanding applications for biomaterials in various industries.
  • Penetrating new geographic markets in Asia and other regions.
  • Developing new biofuel technologies.
  • Capitalizing on the growing demand for sustainable products.

Amenazas

  • Increasing competition from other biomaterial producers.
  • Regulatory changes impacting the chemicals industry.
  • Economic downturns affecting demand for industrial products.
  • Technological advancements rendering existing products obsolete.

Ventajas competitivas

  • Integrated Biorefinery: Borregaard's integrated biorefinery model allows for efficient and sustainable production of a wide range of products from a single raw material (wood).
  • Proprietary Technology: The company's proprietary technology and know-how in wood processing and biomaterial development provide a competitive advantage.
  • Sustainable Sourcing: Borregaard's commitment to sustainable sourcing and environmentally friendly production practices appeals to environmentally conscious customers.
  • Diverse Product Portfolio: The company's diverse product portfolio reduces its reliance on any single product or market, providing stability and resilience.

Acerca de BRGAY

Borregaard ASA, established in 2012 and headquartered in Sarpsborg, Norway, is a global provider of sustainable biomaterials, biochemicals, and biofuels. The company's roots trace back to the wood processing industry, evolving into a sophisticated biorefinery that transforms wood into a range of specialized products. Borregaard operates through three primary segments: BioSolutions, BioMaterials, and Fine Chemicals. The BioSolutions segment offers biopolymers used in agrochemicals, batteries, industrial binders, and construction, as well as biovanillin for the flavor and fragrance industries. The BioMaterials segment produces specialty cellulose for cellulose ethers, cellulose acetate, and cellulose fibrils for industrial applications. The Fine Chemicals segment provides fine chemical intermediates for contrast agents and bioethanol. Borregaard's geographic reach extends across Europe, the United States, Asia, and other international markets. The company's integrated biorefinery model and focus on sustainable practices position it as a key player in the transition towards a bio-based economy.

Qué hacen

  • Develops and produces specialized biomaterials from wood.
  • Creates biochemicals for various industrial applications.
  • Manufactures biofuels as a renewable energy source.
  • Supplies biopolymers for agrochemicals, batteries, and construction.
  • Produces biovanillin for the flavor and fragrance industries.
  • Offers specialty cellulose for cellulose ethers and acetate.
  • Provides fine chemical intermediates for contrast agents.
  • Markets its products globally across Europe, the US, and Asia.

Modelo de Negocio

  • Transforms wood into high-value biomaterials, biochemicals, and biofuels through an integrated biorefinery process.
  • Sells its products to a diverse range of industries, including agrochemicals, food and beverage, and pharmaceuticals.
  • Generates revenue through the sale of its specialized products and licensing of its technology.
  • Focuses on sustainable and environmentally friendly production practices to meet growing demand for green solutions.

Contexto de la Industria

Borregaard ASA operates within the chemicals industry, specifically focusing on biomaterials, biochemicals, and biofuels. The industry is experiencing a growing demand for sustainable and renewable alternatives to traditional fossil-based products. This trend is driven by increasing environmental awareness, stricter regulations, and consumer preferences for eco-friendly solutions. Borregaard's competitors include companies like ALKEF, CUGCY, DALQF, MXCHY, and OCINF, each with varying degrees of focus on biomaterials and sustainable practices. The company's integrated biorefinery model and focus on high-value applications differentiate it from many competitors.

Clientes Clave

  • Agrochemical companies using biopolymers in their formulations.
  • Flavor and fragrance companies utilizing biovanillin as a natural ingredient.
  • Manufacturers of cellulose ethers and cellulose acetate.
  • Pharmaceutical companies requiring fine chemical intermediates.
  • Companies in the food and beverage industry seeking sustainable ingredients.
Confianza de la IA: 71% Actualizado: 17 mar 2026

Finanzas

Gráfico e información

Precio de la acción de Borregaard ASA Unsponsored ADR (BRGAY): Price data unavailable

Últimas noticias

Consenso de analistas

Calificación de Consenso

Recomendaciones agregadas de Compra/Mantener/Vender de Benzinga, Yahoo Finance y Finnhub para BRGAY.

Objetivos de Precios

Análisis del precio objetivo de Wall Street para BRGAY.

MoonshotScore

49/100

¿Qué significa esta puntuación?

El MoonshotScore califica el potencial de crecimiento de BRGAY en una escala de 0 a 100 en múltiples factores, incluyendo innovación, disrupción del mercado, salud financiera e impulso.

Liderazgo: Tom Erik Foss-Jacobsen

CEO

Tom Erik Foss-Jacobsen serves as the CEO of Borregaard ASA, leading a team of 1174 employees. His background includes extensive experience in the chemical and materials industries. He has held various leadership positions in both domestic and international companies, focusing on strategic development, operational excellence, and sustainable growth. Foss-Jacobsen's expertise lies in driving innovation and expanding market share in competitive environments. He is known for his commitment to sustainability and his ability to build strong relationships with stakeholders.

Historial: Under Tom Erik Foss-Jacobsen's leadership, Borregaard ASA has focused on expanding its global presence and strengthening its position as a leader in sustainable biomaterials. Key achievements include the successful launch of new products and the implementation of operational improvements that have enhanced efficiency and profitability. Foss-Jacobsen has also overseen significant investments in research and development, driving innovation in biofuel technologies and biomaterial applications. His strategic decisions have contributed to the company's growth and its commitment to environmental responsibility.

Información de ADR de Borregaard ASA Unsponsored ADR No patrocinado

An American Depositary Receipt (ADR) is a certificate representing shares of a foreign company that trades on U.S. stock exchanges. BRGAY is an unsponsored Level 1 ADR, meaning it trades over-the-counter (OTC) without direct involvement from Borregaard ASA. This allows U.S. investors to invest in Borregaard without dealing with foreign exchanges.

  • Ticker del mercado local: Oslo Stock Exchange (BRGA), Norway
  • Nivel de ADR: 1
  • Ratio de ADR: 1:1
  • Ticker del mercado local: BRGA
Riesgo cambiario: Investing in BRGAY exposes U.S. investors to currency risk, as the ADR's value is affected by fluctuations in the Norwegian Krone (NOK) against the U.S. dollar (USD). If the NOK weakens against the USD, the value of BRGAY may decrease, even if Borregaard's underlying business performs well. Investors may want to evaluate this currency risk when evaluating the potential returns on BRGAY.
Implicaciones fiscales: Dividends paid on BRGAY shares are subject to foreign dividend withholding tax in Norway. The standard withholding tax rate is typically 25%, but this may be reduced depending on tax treaties between Norway and the U.S. Investors should consult with a tax advisor to understand the specific tax implications of owning BRGAY shares.
Horario de negociación: The Oslo Stock Exchange (where BRGA trades) operates from 09:00 to 16:30 Central European Time (CET). This is 3:00 AM to 10:30 AM Eastern Time (ET). Therefore, there is a significant overlap with U.S. trading hours, but U.S. investors may experience limited trading activity during the early morning hours in the U.S.

Información del mercado OTC de BRGAY

The OTC Other tier represents the lowest tier of the over-the-counter (OTC) market. Companies in this tier often have limited financial disclosure and may not meet the listing requirements of major exchanges like the NYSE or NASDAQ. Investing in OTC Other stocks carries higher risks compared to exchange-listed stocks due to the potential for limited liquidity, price volatility, and lack of regulatory oversight.

  • Nivel OTC: OTC Other
  • Estado de divulgación: Unknown
Liquidez: As an OTC Other stock, BRGAY likely has limited liquidity compared to exchange-listed stocks. This can result in wider bid-ask spreads and difficulty in buying or selling large quantities of shares without significantly impacting the price. Investors should be aware of these potential liquidity constraints when trading BRGAY.
Factores de riesgo OTC:
  • Limited financial disclosure and transparency.
  • Potential for low trading volume and liquidity.
  • Higher price volatility compared to exchange-listed stocks.
  • Lack of regulatory oversight and investor protection.
  • Increased risk of fraud or manipulation.
Lista de verificación de diligencia debida:
  • Verify the company's registration and legal status.
  • Obtain and review available financial statements.
  • Assess the company's business model and competitive landscape.
  • Evaluate the management team and their track record.
  • Understand the risks associated with the OTC market.
  • Consult with a financial advisor.
  • Monitor news and developments related to the company.
Señales de legitimidad:
  • Established business operations and history.
  • Presence of a reputable management team.
  • Positive news coverage and industry recognition.
  • Availability of some financial information, even if limited.
  • Active investor relations and communication.

Acciones de Borregaard ASA Unsponsored ADR: Preguntas Clave Respondidas

¿Cuáles son los factores clave para evaluar BRGAY?

Borregaard ASA Unsponsored ADR (BRGAY) actualmente tiene una puntuación IA de 49/100, indicando puntuación baja. Fortaleza clave: Integrated biorefinery model for efficient production.. Riesgo principal a monitorear: Potential: Fluctuations in raw material prices (wood) impacting profitability.. Esto no es asesoramiento financiero.

¿Qué es el MoonshotScore de BRGAY?

BRGAY actualmente puntúa 49/100 (Grado D) en el MoonshotScore, lo que sugiere calificación baja. La puntuación evalúa el potencial de crecimiento, la salud financiera, el impulso del mercado y los factores de riesgo en 9 KPIs cuantitativos. Se recalcula diariamente con los últimos datos del mercado. Esta puntuación es solo informativa.

¿Con qué frecuencia se actualizan los datos de BRGAY?

Los precios de BRGAY se actualizan en tiempo real durante el horario del mercado estadounidense (9:30-16:00 ET, días laborables). Los fundamentales se actualizan después de los informes trimestrales o anuales. Las calificaciones de analistas y las perspectivas de IA se actualizan diariamente. Las noticias se agregan continuamente de fuentes financieras.

¿Qué dicen los analistas sobre BRGAY?

La cobertura de analistas para BRGAY incluye calificaciones de consenso (compra, mantener, venta), objetivos de precio a 12 meses y estimaciones de ganancias de las principales firmas de investigación. Consulte la sección de Consenso de Analistas en esta página.

¿Cuáles son los riesgos de invertir en BRGAY?

Las categorías de riesgo para BRGAY incluyen riesgo de mercado, riesgo específico de la empresa (gestión, competencia), riesgo financiero (deuda, consumo de efectivo) y riesgo macroeconómico (tasas, inflación). Un riesgo clave identificado: Potential: Fluctuations in raw material prices (wood) impacting profitability.. Un beta superior a 1,0 indica mayor volatilidad que el S&P 500. Revise la sección de Factores de Riesgo en esta página. Todas las inversiones conllevan riesgo de pérdida.

¿Cuál es la relación P/E de BRGAY?

La relación P/E para BRGAY compara el precio actual de la acción con sus ganancias por acción. Un P/E más alto puede indicar expectativas de crecimiento, mientras que un P/E más bajo puede sugerir valor. Consulte la pestaña de Financieros para métricas actuales.

¿Está BRGAY sobrevalorada o infravalorada?

Determinar si Borregaard ASA Unsponsored ADR (BRGAY) está sobrevalorada o infravalorada requiere examinar múltiples métricas. Compare los ratios de valoración (P/E, P/S, EV/EBITDA) con pares del sector. Esto no es asesoramiento financiero.

¿Cuál es el rendimiento por dividendo de BRGAY?

Borregaard ASA Unsponsored ADR (BRGAY) actualmente no paga un dividendo regular, o los datos de rendimiento no están disponibles. Consulte la pestaña de Financieros para información actual.

Descargo de responsabilidad: Este contenido es solo para fines informativos y no constituye asesoramiento de inversión. Siempre haga su propia investigación y consulte a un asesor financiero.

Recursos Oficiales

Análisis actualizado el Puntuación de IA actualizada diariamente
Fuentes de Datos y Metodología
Datos de mercado proporcionados por Financial Modeling Prep y Yahoo Finance. Análisis de IA por algoritmos propietarios de Stock Expert AI. Indicadores técnicos mediante cálculos estándar de la industria. Última actualización: .

Datos proporcionados solo con fines informativos.

Notas de análisis
  • Limited analyst coverage for BRGAY due to its OTC listing.
  • Disclosure status on OTC markets is unknown, requiring extra due diligence.
Fuentes de datos

Popular Stocks